Group structure
11 companies in 3 countries
Loading your pageโฆ
11 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DEGIL SUN 30 SPF FPS2 % / w/w + 10.5 % / w/w + 5 % / w/w + 2 % / w/w + 2 % / w/w ยท Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone | Canada | Marketed | 2023 |
| DEGIL SUN 50 SPF FPS3 % / w/w + 13 % / w/w + 5 % / w/w + 7 % / w/w + 4 % / w/w ยท Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone | Canada | Marketed | 2024 |
| ZINC PLUS VITAMINS C & B6 LOZENGES60 mg / loz + 5 mg / loz + 15 mg / loz ยท Lozenge | Ascorbic acid, Vitamin b6, Zinc | Canada | Authorised | |
| AGRO-SQUAD 2-14.34 % + 1.953 % + 1.302 % + 3.255 % ยท Liquid | Benzalkonium, Didecyl dimethyl ammonium, Dioctyl dimethyl ammonium, Octyl decyl dimethyl ammonium | Canada | Cancelled | 1996 |
| DIGECAP | Bromoprida | Brazil | Cancelled | 1996 |
| ORA-PLUS HIGH POTENCY MULTIVITAMIN AND MULTIMINERAL SUPPLEMENT150 mg + 2500 unit + 10 mcg + 40 mg + 72.5 mg + 20 mcg + 0.1 mg + 50 mg + 17.5 mg + 0.04 mg + 4 mg + 0.005 mg + 1 mg + 40 mg + 0.5 mg + 10 mg + 0.04 mg + 20 mcg + 20 mg + 25 mcg + 5 mg + 15 mg + 65 unit + 65 unit + 3 mg ยท Tablet | Ascorbic acid, Beta-carotene, Biotin, Calcium, Choline, Chromium, Copper, D-pantothenic acid, Dl-methionine, Folic acid, Inositol, Iodine, Iron, Magnesium, Manganese, Nicotinic acid, Potassium, Selenium, Vitamin b1, Vitamin b12, Vitamin b2, Vitamin b6, Vitamin d, Vitamin e, Zinc | Canada | Cancelled | 2003 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 5 | 3 | 2 | CompaniesAll medicines |
| Brazil | 1 | 0 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
INSEE (www.insee.fr), via DINUM API Recherche dโentreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Oficiul Naศional al Registrului Comerศului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.